Filgrastim Biosimilars Market Size is predicted to expand with a 8.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Governments around the world are promoting the use of biosimilars through...
Prevention of progression and proliferation of infectious diseases in the body has always been the point of discussion, which has developed a throng of techniques to alter these effects of the immune system. Immunotherapy is a treatment that uses par...
Global Bevacizumab Biosimilar Market is expected to grow at an 9.0% CAGR during the forecast period for 2025-2034. Bevacizumab is a recombinant humanized monoclonal antibody that neutralizes vascular endothelial growth factor A (VEGF-A) biologic act...
TNF Biosimilars Market is expected to grow at a 16.5% CAGR during the forecast period for 2025-2034. Tumor necrosis factors are a group of cytokines that are secreted by macrophages and may induce cell death of certain tumor cell lines, whic...
The Global Clinical Trial Services Market size is valued at USD 22.58 billion in 2023 and is predicted to reach USD 42.86 billion by the year 2031 at an 8.44% CAGR during the forecast period for 2024-2031. The se...
The Deep Vein Thrombosis Market Size is valued at 958.11 Million in 2022 and is predicted to reach 1343.86 Million by the year 2031 at a 4.0 % CAGR during the forecast period for 2023-2031. Deep vein thrombosis (DVT) is a serious condition that oc...
The Breast Cancer Market is expected to grow at an 8.8% CAGR during the forecast period for 2024-2031. Breast cancer start when cells in the breast begin to grow out of control. These cells form tumour that can often see on an x-ray. Breast ca...
The Etanercept Biosimilar Market Size is valued at XX Million in 2024 and is predicted to reach XX Million by the year 2034 at an 17.8% CAGR during the forecast period for 2025-2034. Etanercept is a tumor necrosis factor alpha (TNF-&alph...
The Ovarian Cancer Market is expected to grow at a 10.5% CAGR during the forecast period for 2024-2031. Ovarian cancer rank fifth in cancer deaths among women and accounting for more deaths than any other cancer of the female reproductive syst...
The preceding decades have shown higher incidence and prevalence trends for cancer. Globally, the scenario is worsening with the mounting number of cancer patients every year. The number of new cancer cases is predicted to rise by 54% within the next...
Pharmaceuticals